PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant...

por Zuco, Valentina, De Cesare, Michelandrea, Zaffaroni, Nadia, Lanzi, Cinzia, Cassinelli, Giuliana
Publicado 2015

Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel In Vitro and In Vivo

por Zuco, Valentina, De Cesare, Michelandrea, Cincinelli, Raffaella, Nannei, Raffaella, Pisano, Claudio, Zaffaroni, Nadia, Zunino, Franco
Publicado 2011

High efficacy of CpG-ODN, Cetuximab and Cisplatin combination for very advanced ovarian xenograft tumors

por Sommariva, Michele, de Cesare, Michelandrea, Meini, Alessandra, Cataldo, Alessandra, Zaffaroni, Nadia, Tagliabue, Elda, Balsari, Andrea
Publicado 2013

Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism

por El Bezawy, Rihan, De Cesare, Michelandrea, Pennati, Marzia, Deraco, Marcello, Gandellini, Paolo, Zuco, Valentina, Zaffaroni, Nadia
Publicado 2017

Efficacy of a Selective Binder of α(V)β(3) Integrin Linked to the Tyrosine Kinase Inhibitor Sunitinib in Ovarian Carcinoma Preclinical Models

por Sartori, Andrea, Corno, Cristina, De Cesare, Michelandrea, Scanziani, Eugenio, Minoli, Lucia, Battistini, Lucia, Zanardi, Franca, Perego, Paola
Publicado 2019

CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts

por De Cesare, Michelandrea, Sfondrini, Lucia, Pennati, Marzia, De Marco, Cinzia, Motta, Valentina, Tagliabue, Elda, Deraco, Marcello, Balsari, Andrea, Zaffaroni, Nadia
Publicado 2016

Synthesis and Evaluation of the Tumor Cell Growth Inhibitory Potential of New Putative HSP90 Inhibitors

por Bizarro, Ana, Sousa, Diana, Lima, Raquel T., Musso, Loana, Cincinelli, Raffaella, Zuco, Vantina, De Cesare, Michelandrea, Dallavalle, Sabrina, Vasconcelos, M. Helena
Publicado 2018

Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin

por De Cesare, Michelandrea, Cominetti, Denis, Doldi, Valentina, Lopergolo, Alessia, Deraco, Marcello, Gandellini, Paolo, Friedlander, Sharon, Landesman, Yosef, Kauffman, Michael G., Shacham, Sharon, Pennati, Marzia, Zaffaroni, Nadia
Publicado 2015

miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma

por El Bezawy, Rihan, Percio, Stefano, Ciniselli, Chiara Maura, De Cesare, Michelandrea, Colella, Gennaro, Dugo, Matteo, Veneroni, Silvia, Doldi, Valentina, Martini, Silvia, Baratti, Dario, Kusamura, Shigeki, Verderio, Paolo, Deraco, Marcello, Gandellini, Paolo, Zaffaroni, Nadia, Zuco, Valentina
Publicado 2022